...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
【24h】

Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.

机译:用于测量IGF-II,IGFBP-2和-3以及ICTP的免疫测定法,可作为重组人生长激素在体育运动中滥用的间接生物标记。选定运动员群体的价值。

获取原文
获取原文并翻译 | 示例
           

摘要

Insulin-like growth factor-II (IGF-II), insulin-like growth factor binding proteins (IGFBPs) -2 and -3 and C-terminal telopeptide of type I collagen (ICTP) have been proposed, among others, as indirect biomarkers of the recombinant human growth hormone misuse in sport. An extended intra- and inter-laboratory validation of commercially available immunoassays for biomarkers detection was performed. ELISA assays for total IGF-II, IGFBP-2 and IGFBP-3 (IGF-II/ELISA1: DSLabs, IGFBP-2/ELISA2: Biosource, and IGFBP-3/ELISA3: BioSource) and an EIA assay for ICTP (ICTP/EIA: Orion Diagnostica) were evaluated. The inter- and intra-laboratory precision values were acceptable for all evaluated assays (maximum imprecision of 30% and 66% were found only for the lowest quality control samples of IGF-II and IGFBP-3). Correct accuracy was obtained for all inter-laboratory immunoassays and for IGFBP-2 intra-laboratory immunoassay. The range of concentrations found in serum samples under investigation was always covered by the calibration curves of the studied immunoassays. However, 11% and 15% of the samples felt below the estimated LOQ for IGF-II and ICTP, respectively, in the zone where lower precision was obtained. Although the majority of evaluated assays showed an overall reliability not always suitable for antidoping control analysis, relatively high concordances between laboratory results were obtained for all assays. Evaluated immunoassays were used to measure serum concentrations of IGF-II, IGFBP-2 and -3 and ICTP in elite athletes of various sport disciplines at different moments of the training season; in recreational athletes at baseline conditions and finally in sedentary individuals. Serum IGF-II was statistically higher both in recreational and elite athletes compared to sedentary individuals. Elite athletes showed lower IGFBP-2 and higher IGFBP-3 concentration with respect to recreational athletes and sedentary people. Among elite athletes, serum IGFBP-3 (synchronized swimming), and ICTP (rhythmic gymnastics) concentrations were sport-dependent. Over the training season, within athlete variability was observed for IGFBP-2 in case of taekwondo and IGFBP-2 and -3 in case of weightlifting. Variations due to those aspects should be taken in careful consideration in the hypothesis of setting reference concentration ranges for doping detection.
机译:胰岛素样生长因子II(IGF-II),胰岛素样生长因子结合蛋白(IGFBPs)-2和-3和I型胶原C端端肽(ICTP)已被提议作为间接生物标志物重组人生长激素在体育运动中的滥用对用于生物标志物检测的市售免疫测定法进行了实验室内和实验室间的扩展验证。进行总IGF-II,IGFBP-2和IGFBP-3的ELISA分析(IGF-II / ELISA1:DSLabs,IGFBP-2 / ELISA2:Biosource和IGFBP-3 / ELISA3:BioSource),以及针对ICTP的EIA分析(ICTP / EIA:Orion Diagnostica)进行了评估。实验室间和实验室内的精密度值对于所有评估的测定都是可以接受的(仅对于最低质量的IGF-II和IGFBP-3对照样品,发现最大不准确度为30%和66%)。所有实验室间免疫测定和IGFBP-2实验室内免疫测定均获得正确的准确性。在研究的血清样本中发现的浓度范围始终被所研究的免疫测定的校准曲线所覆盖。但是,在获得较低精度的区域中,分别有11%和15%的样本感觉低于IGF-II和ICTP的估计LOQ。尽管大多数评估分析显示出总的可靠性并不总是适用于反掺杂对照分析,但是所有分析的实验室结果之间都具有相对较高的一致性。评价的免疫分析方法用于在训练季节的不同时刻测量各种运动学科的精英运动员的血清IGF-II,IGFBP-2和-3和ICTP的浓度。在基线状态的休闲运动员中,最后在久坐的人中。与久坐的人相比,休闲和精英运动员的血清IGF-II在统计学上都更高。相对于休闲运动员和久坐的人,优秀运动员的IGFBP-2浓度较低,而IGFBP-3浓度较高。在优秀运动员中,血清IGFBP-3(花样游泳)和ICTP(艺术体操)的浓度与运动有关。在整个训练季节,跆拳道运动员的IGFBP-2,举重运动员的IGFBP-2和-3均在运动员内部波动。在为掺杂检测设置参考浓度范围的假设中,应仔细考虑由于这些方面而引起的变化。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号